Bakkt (BKKT) Q2 2026 earnings review
Paper Gains Mask Core Revenue Collapse
Bakkt reported a dramatic 70% YoY revenue decline in Q2, driven by client transitions and broader digital asset market softness. While the company posted an optically impressive Net Income of $80.8 million, this was entirely fueled by a $98.5 million non-cash mark-to-market gain on its Transchem warrant position. Underlying operational profitability remains negative, with the Adjusted EBITDA loss widening to $11.8 million. Management insists the foundational restructuring is complete and the company is entering an 'acceleration phase,' but the gap between the visionary narrative and current operating reality requires an unprecedented H2 revenue ramp to validate.
🐂 Bull Case
The painful divestiture of non-core assets (Loyalty, Trust) is complete. Bakkt now boasts a clean, debt-free balance sheet with $50.7M in cash to fund its pure-play crypto infrastructure pivot.
The capital-light global expansion strategy is bearing fruit on paper. 'Strategic Asset Value' reached $118.5M across the Bitcoin Japan and Transchem (India) positions, dwarfing the initial capital deployed.
🐻 Bear Case
Q2 crypto revenue of $170.1M was almost entirely offset by $169.3M in crypto costs and execution fees. The business currently operates with razor-thin margins prior to heavy SG&A and development costs.
Management's narrative is heavily promotional, focusing on multi-trillion dollar TAMs rather than current cash flows. Hitting the $2.5B annual volume guidance requires a massive, flawless conversion of a still-unproven B2B pipeline.
⚖️ Verdict: 🔴
Bearish. While the balance sheet survival risk has been mitigated, the core operating business is decelerating sharply. The reliance on non-cash mark-to-market gains to generate positive net income obscures worsening underlying profitability.
Key Themes
Contradiction: Record Profits Mask Expanding Core Losses
Net income reversed dramatically from a $14.7M loss last year to a positive $80.8M this quarter. However, this contradicts the actual operating performance. The profit was entirely manufactured by a $98.5M non-cash fair value gain on Transchem warrants and a $1.4M legacy warrant gain. Stripping out paper gains, Adjusted EBITDA loss actually expanded from $9.8M to $11.8M YoY. Operating profitability is decelerating, not improving.
Hockey-Stick Volume Guidance Relies on H2 Miracle
Management reiterated FY26 guidance for Total Transacting Volume (TTV) of ~$2.5B. However, H1 TTV was just $410M (with Q2 decelerating sequentially to $168.8M vs an implied $241.2M in Q1). This means Bakkt must generate ~$2.1B in H2—a 5x acceleration vs H1. This implies extreme dependence on pending pipeline activations (like the Zoth partnership) launching without a single technical or regulatory delay.
DTR Tech Integration and Stablecoin Rails
The acquisition of DTR closed in April, bringing crucial payment and stablecoin infrastructure in-house. This quarter marked the first time payments volume processed through the acquired infrastructure was included in TTV. Connecting traditional bank rails to stablecoin settlement via a single API (Zyra) transitions Bakkt from a simple spot trading venue into a full-spectrum payments processor.
Capital-Light Global Footprint via Strategic Assets
Bakkt is scaling internationally without heavy CapEx by taking strategic positions in local entities. Following regulatory approval, Bakkt was allotted 47.5M Transchem warrants in India. Combined with the Bitcoin Japan investment, this 'Bakkt Global' engine brings the company's Strategic Asset Value (SAV) to $118.5M on just ~$21M of deployed capital.
Regulatory Moat as a Primary Product
Bakkt views its pan-U.S. Money Transmitter Licenses (MTLs) and New York BitLicense as its strongest barrier to entry. With looming macro shifts and legislation like the GENIUS and CLARITY Acts expected to raise compliance costs, Bakkt is selling its 'regulatory wrapper' to global stablecoin providers who want U.S. access but cannot afford the time or cost to build their own compliance stack.
Macro Tailwinds: The Stablecoin TAM
Management continues to frame the company against a massive macro backdrop: a $200-$300 trillion legacy payments market converging with a $33 trillion (and rapidly growing) stablecoin settlement market. The structural shift toward blockchain-based cross-border remittance provides a heavy secular tailwind, provided Bakkt can successfully deploy its embedded finance APIs to capture volume.
Severe Revenue Contraction
Total revenue crashed 70% YoY to $170.1M, primarily reflecting the loss/restructuring of the Webull client relationship and industry-wide softness in digital asset trading volumes. The company is actively shedding its legacy revenue base before its new 'Three Engine' strategy has fully commercialized, leaving a precarious air pocket in the P&L.
Other KPIs
Stable liquidity position post-restructuring. Cash increased from $27.5M at the end of FY25, supported by $69.6M in gross proceeds from recent equity offerings, even after funding the $9.4M Transchem subscription. The company holds zero long-term debt.
Decelerating sequentially. H1 totaled $410.0M, meaning Q1 contributed roughly $241.2M. While Q2 saw the first inclusion of acquired DTR payment volumes, the base trading volume clearly remains under heavy pressure.
Stable YoY (up slightly from $19.0M in 25Q2). Includes two months of acquired DTR operating costs and professional services for the India strategy. The company has successfully defended its baseline cost structure post-Loyalty divestiture.
Guidance
Accelerating wildly. Given H1 actuals of $410M, this implies H2 volume must scale to roughly $2.1 billion. Management assumes client integrations currently underway will launch and scale flawlessly in H2.
Accelerating. A newly introduced KPI based on end-users completing qualifying activities in Bakkt Agent-powered products. Relies on the Q4 launch of co-branded cards and Neobank-as-a-Service partnerships.
Key Questions
Revenue Realization from TTV
With a target of $2.5B in Total Transacting Volume for FY26, what is the blended take-rate or revenue margin you expect to capture from this volume, given that your current $170M in crypto revenue yields almost zero gross profit?
Monetizing Strategic Assets
Your Strategic Asset Value sits at nearly $120M, driving this quarter's net income. However, these are illiquid or restricted international equity/warrant positions. What is the timeline and mechanism for converting these paper gains into actual cash flow to fund operations?
Bridging the H2 Volume Gap
Hitting the $2.5B TTV guidance requires a $2.1B ramp in the second half of the year. Which specific partner activations (e.g., Zoth) are hard-scheduled for Q3 to ensure this hockey-stick growth doesn't slip into 2027?